Literature DB >> 17106690

A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome.

Joyce Geelen1, Koen van den Dries, Anja Roos, Nicole van de Kar, Corrie de Kat Angelino, Ina Klasen, Leo Monnens, Lambertus van den Heuvel.   

Abstract

A genetic predisposition involving complement regulatory genes has become evident in some patients with atypical HUS. In this paper, a patient with a heterozygous missense mutation in factor I (IF) is described. Although the serum level of IF was normal, a mild functional defect in the alternative pathway of complement could be demonstrated in the affected members of the family. After an episode of atypical HUS, chronic renal insufficiency started at the age of 15 months. Recurrence of HUS, with loss of the renal transplant, occurred twice in this patient. The recurrence of HUS in the graft was not reflected by haematological abnormalities (haemolysis, thrombocytopenia). One additional transplant was lost due to arterial thrombosis of the renal artery. This report confirms the gloomy outcome of renal transplants in patients with an IF deficiency. New therapies should be evaluated in these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17106690     DOI: 10.1007/s00467-006-0320-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

1.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

Review 2.  Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.

Authors:  Marie-Agnès Dragon-Durey; Véronique Frémeaux-Bacchi
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

3.  Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones.

Authors:  C F Catterall; A Lyons; R B Sim; A J Day; T J Harris
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

4.  Complement factor I deficiency associated with recurrent infections, vasculitis and immune complex glomerulonephritis.

Authors:  Ferah Genel; Anders G Sjöholm; Lillemor Skattum; Lennart Truedsson
Journal:  Scand J Infect Dis       Date:  2005

5.  Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice.

Authors:  M C Pickering; J Warren; K L Rose; F Carlucci; Y Wang; M J Walport; H T Cook; M Botto
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

6.  Local synthesis of complement component C3 regulates acute renal transplant rejection.

Authors:  Julian R Pratt; Shamim A Basheer; Steven H Sacks
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

7.  Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria.

Authors:  Anita Hill; Peter Hillmen; Stephen J Richards; Dupe Elebute; Judith C Marsh; Jason Chan; Christopher F Mojcik; Russell P Rother
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

8.  Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome.

Authors:  David Kavanagh; Elizabeth J Kemp; Elizabeth Mayland; Robin J Winney; Jeremy S Duffield; Graham Warwick; Anna Richards; Roy Ward; Judith A Goodship; Timothy H J Goodship
Journal:  J Am Soc Nephrol       Date:  2005-05-25       Impact factor: 10.121

9.  Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation.

Authors:  C González-Rubio; A Ferreira-Cerdán; I M Ponce; J Arpa; G Fontán; M López-Trascasa
Journal:  Arch Neurol       Date:  2001-11

10.  Three cases of factor I deficiency: the effect of treatment with plasma.

Authors:  J Møller Rasmussen; B Teisner; H H Jepsen; S E Svehag; F Knudsen; H Kirstein; M Buhl
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

View more
  12 in total

1.  Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient.

Authors:  Micah R Chan; Christie P Thomas; Jose R Torrealba; Arjang Djamali; Luis A Fernandez; Carla J Nishimura; Richard J H Smith; Millie D Samaniego
Journal:  Am J Kidney Dis       Date:  2008-09-21       Impact factor: 8.860

Review 2.  New insights into postrenal transplant hemolytic uremic syndrome.

Authors:  Julien Zuber; Moglie Le Quintrec; Rebecca Sberro-Soussan; Chantal Loirat; Véronique Frémeaux-Bacchi; Christophe Legendre
Journal:  Nat Rev Nephrol       Date:  2010-11-23       Impact factor: 28.314

Review 3.  aHUS caused by complement dysregulation: new therapies on the horizon.

Authors:  Aoife M Waters; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2010-06-18       Impact factor: 3.714

Review 4.  Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.

Authors:  M Noris; G Remuzzi
Journal:  Clin Exp Immunol       Date:  2007-12-07       Impact factor: 4.330

5.  Complete factor I deficiency due to dysfunctional factor I with recurrent aseptic meningo-encephalitis.

Authors:  Filomeen Haerynck; Patrick Stordeur; Johan Vandewalle; Rudy Van Coster; Victoria Bordon; Frans De Baets; Petra Schelstraete; Cédric Javaux; Marie-Rose Bouvry; Véronique Fremeaux-Bacchi; Joke Dehoorne
Journal:  J Clin Immunol       Date:  2013-10-20       Impact factor: 8.317

6.  Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.

Authors:  Jeffrey M Saland; Benjamin L Shneider; Jonathan S Bromberg; Patricia A Shi; Stephen C Ward; Margret S Magid; Corinne Benchimol; Mouin G Seikaly; Sukru H Emre; Elena Bresin; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 8.237

Review 7.  Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature.

Authors:  Sami Alasfar; Nada Alachkar
Journal:  Front Med (Lausanne)       Date:  2014-12-12

8.  Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation.

Authors:  Jean Claude Davin; Lisa Strain; Tim H J Goodship
Journal:  Pediatr Nephrol       Date:  2008-05-16       Impact factor: 3.714

9.  Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration.

Authors:  Johanna M Seddon; Yi Yu; Elizabeth C Miller; Robyn Reynolds; Perciliz L Tan; Sivakumar Gowrisankar; Jacqueline I Goldstein; Michael Triebwasser; Holly E Anderson; Jennyfer Zerbib; David Kavanagh; Eric Souied; Nicholas Katsanis; Mark J Daly; John P Atkinson; Soumya Raychaudhuri
Journal:  Nat Genet       Date:  2013-09-15       Impact factor: 38.330

Review 10.  Atypical hemolytic uremic syndrome.

Authors:  David Kavanagh; Tim H Goodship; Anna Richards
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.